Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients.

Shahmansouri N, Farokhnia M, Abbasi SH, Kassaian SE, Noorbala Tafti AA, Gougol A, Yekehtaz H, Forghani S, Mahmoodian M, Saroukhani S, Arjmandi-Beglar A, Akhondzadeh S.

J Affect Disord. 2014 Feb;155:216-22. doi: 10.1016/j.jad.2013.11.003. Epub 2013 Nov 16.

PMID:
24289892
2.

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.

Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH.

J Ethnopharmacol. 2005 Feb 28;97(2):281-4. Epub 2005 Jan 6.

PMID:
15707766
3.

Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.

Kashani L, Eslatmanesh S, Saedi N, Niroomand N, Ebrahimi M, Hosseinian M, Foroughifar T, Salimi S, Akhondzadeh S.

Pharmacopsychiatry. 2017 Mar;50(2):64-68. doi: 10.1055/s-0042-115306. Epub 2016 Sep 5.

PMID:
27595298
4.

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.

Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, Amini H, Fallah-Pour H, Jamshidi AH, Khani M.

Phytother Res. 2005 Feb;19(2):148-51.

PMID:
15852492
5.

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.

Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):439-42. Epub 2006 Dec 15.

PMID:
17174460
6.

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.

Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S.

Phytomedicine. 2006 Nov;13(9-10):607-11. Epub 2006 Sep 18.

PMID:
16979327
7.

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.

Abbasi SH, Mohammadinejad P, Shahmansouri N, Salehiomran A, Beglar AA, Zeinoddini A, Forghani S, Akhondzadeh S.

J Affect Disord. 2015 Sep 1;183:149-55. doi: 10.1016/j.jad.2015.04.049. Epub 2015 May 7.

PMID:
26005776
8.
9.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
10.

Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study.

Kashani L, Raisi F, Saroukhani S, Sohrabi H, Modabbernia A, Nasehi AA, Jamshidi A, Ashrafi M, Mansouri P, Ghaeli P, Akhondzadeh S.

Hum Psychopharmacol. 2013 Jan;28(1):54-60. doi: 10.1002/hup.2282. Epub 2012 Dec 20.

PMID:
23280545
11.

Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.

Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S.

BJOG. 2008 Mar;115(4):515-9. doi: 10.1111/j.1471-0528.2007.01652.x.

12.

A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression.

Tabeshpour J, Sobhani F, Sadjadi SA, Hosseinzadeh H, Mohajeri SA, Rajabi O, Taherzadeh Z, Eslami S.

Phytomedicine. 2017 Dec 1;36:145-152. doi: 10.1016/j.phymed.2017.10.005. Epub 2017 Oct 7.

PMID:
29157808
13.

Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.

Talaei A, Hassanpour Moghadam M, Sajadi Tabassi SA, Mohajeri SA.

J Affect Disord. 2015 Mar 15;174:51-6. doi: 10.1016/j.jad.2014.11.035. Epub 2014 Nov 26.

PMID:
25484177
14.

Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.

Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SSh, Yousefi MH, Alimardani R, Jamshidi A, Zare F, Moradi A.

J Clin Pharm Ther. 2010 Oct;35(5):581-8. doi: 10.1111/j.1365-2710.2009.01133.x.

PMID:
20831681
15.

Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

Strik JJ, Honig A, Lousberg R, Lousberg AH, Cheriex EC, Tuynman-Qua HG, Kuijpers PM, Wellens HJ, Van Praag HM.

Psychosom Med. 2000 Nov-Dec;62(6):783-9.

PMID:
11138997
16.

Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine.

Harrer G, Schmidt U, Kuhn U, Biller A.

Arzneimittelforschung. 1999 Apr;49(4):289-96.

PMID:
10337446
17.

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].

Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F.

BMC Complement Altern Med. 2004 Sep 2;4:12.

18.

Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial.

Ghajar A, Neishabouri SM, Velayati N, Jahangard L, Matinnia N, Haghighi M, Ghaleiha A, Afarideh M, Salimi S, Meysamie A, Akhondzadeh S.

Pharmacopsychiatry. 2017 Jul;50(4):152-160. doi: 10.1055/s-0042-116159. Epub 2016 Oct 4.

PMID:
27701683
20.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.

J Clin Psychiatry. 1991 Aug;52(8):329-35.

PMID:
1907963

Supplemental Content

Support Center